Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 73 entries
Sorted by: Best Match Show Resources per page
Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance.

Human psychopharmacology

McAndrews MP, Kayumov L, Phillipson R, Shapiro CM.
PMID: 12404610
Hum Psychopharmacol. 2000 Dec;15(8):583-587. doi: 10.1002/hup.226.

Benzodiazepines produce memory disturbance after acute administration. It is not clear whether chronic use of benzodiazepines is hazardous to memory processes. Epidemiological data indicate that a large proportion (10-30 per cent) of individuals with sleep dysfunction take hypnotic aids...

Cite
McAndrews MP, Kayumov L, Phillipson R, et al. Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance. Hum Psychopharmacol. 2000;15(8):583-587doi: 10.1002/hup.226.
McAndrews, M. P., Kayumov, L., Phillipson, R., & Shapiro, C. M. (2000). Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance. Human psychopharmacology, 15(8), 583-587. https://doi.org/10.1002/hup.226
McAndrews, Mary Pat, et al. "Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance." Human psychopharmacology vol. 15,8 (2000): 583-587. doi: https://doi.org/10.1002/hup.226
McAndrews MP, Kayumov L, Phillipson R, Shapiro CM. Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance. Hum Psychopharmacol. 2000 Dec;15(8):583-587. doi: 10.1002/hup.226. PMID: 12404610.
Copy Download .nbib Format: NLM
Eszopiclone: its use in the treatment of insomnia.

Neuropsychiatric disease and treatment

Monti JM, Pandi-Perumal SR.
PMID: 19300573
Neuropsychiatr Dis Treat. 2007 Aug;3(4):441-53.

Eszopiclone is the S-isomer of racemic zopiclone, a cyclopyrrolone with sedative-hypnotic activity that has been available in Europe, Canada, and Latin America since 1987. Eszopiclone acts by binding to the GABA(A) receptor. In contrast to the benzodiazepine (BZD) hypnotics,...

Cite
Monti JM, Pandi-Perumal SR. Eszopiclone: its use in the treatment of insomnia. Neuropsychiatr Dis Treat. 2007;3(4):441-53
Monti, J. M., & Pandi-Perumal, S. R. (2007). Eszopiclone: its use in the treatment of insomnia. Neuropsychiatric disease and treatment, 3(4), 441-53.
Monti, Jaime M, and Pandi-Perumal, S R. "Eszopiclone: its use in the treatment of insomnia." Neuropsychiatric disease and treatment vol. 3,4 (2007): 441-53.
Monti JM, Pandi-Perumal SR. Eszopiclone: its use in the treatment of insomnia. Neuropsychiatr Dis Treat. 2007 Aug;3(4):441-53. PMID: 19300573; PMCID: PMC2655082.
Copy Download .nbib Format: NLM
Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests.

Journal of psychopharmacology (Oxford, England)

Mattila MJ, Aranko K, Mattila ME, Paakkari I.
PMID: 22298533
J Psychopharmacol. 1994 Jan;8(2):81-7. doi: 10.1177/026988119400800202.

The digit-symbol substitution test (DSST), performed with paper and pencil or computerized, is widely used to reveal decrements in human attention and cognition. We programmed sets of adjustable tasks (digit-symbol, digit-digit, symbol-digit, symbol-symbol) into a microcomputer and compared the...

Cite
Mattila MJ, Aranko K, Mattila ME, et al. Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests. J Psychopharmacol. 1994;8(2):81-7doi: 10.1177/026988119400800202.
Mattila, M. J., Aranko, K., Mattila, M. E., & Paakkari, I. (1994). Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests. Journal of psychopharmacology (Oxford, England), 8(2), 81-7. https://doi.org/10.1177/026988119400800202
Mattila, M J, et al. "Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests." Journal of psychopharmacology (Oxford, England) vol. 8,2 (1994): 81-7. doi: https://doi.org/10.1177/026988119400800202
Mattila MJ, Aranko K, Mattila ME, Paakkari I. Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests. J Psychopharmacol. 1994 Jan;8(2):81-7. doi: 10.1177/026988119400800202. PMID: 22298533.
Copy Download .nbib Format: NLM
Differential illness intrusiveness associated with sleep-promoting medications.

European psychiatry : the journal of the Association of European Psychiatrists

Devins G, Flanigan M, Fleming J, Morehouse R, Moscovitch A, Plamondon J, Reinish L, Shapiro C.
PMID: 19698412
Eur Psychiatry. 1995;10:153s-9s. doi: 10.1016/0924-9338(96)80097-6.

Differences in daytime sleepiness, lifestyle disruptions, and emotional distress were compared across nine groups taking sleep-promoting substances. Groups included individuals taking zopiclone (n = 274), amitriptyline (n = 107), lorazepam (n = 258), oxazepam (n= 141), diphenhydramine HCl (n...

Cite
Devins G, Flanigan M, Fleming J, et al. Differential illness intrusiveness associated with sleep-promoting medications. Eur Psychiatry. 1995;10:153s-9sdoi: 10.1016/0924-9338(96)80097-6.
Devins, G., Flanigan, M., Fleming, J., Morehouse, R., Moscovitch, A., Plamondon, J., Reinish, L., & Shapiro, C. (1995). Differential illness intrusiveness associated with sleep-promoting medications. European psychiatry : the journal of the Association of European Psychiatrists, 10153s-9s. https://doi.org/10.1016/0924-9338(96)80097-6
Devins, G, et al. "Differential illness intrusiveness associated with sleep-promoting medications." European psychiatry : the journal of the Association of European Psychiatrists vol. 10 (1995): 153s-9s. doi: https://doi.org/10.1016/0924-9338(96)80097-6
Devins G, Flanigan M, Fleming J, Morehouse R, Moscovitch A, Plamondon J, Reinish L, Shapiro C. Differential illness intrusiveness associated with sleep-promoting medications. Eur Psychiatry. 1995;10:153s-9s. doi: 10.1016/0924-9338(96)80097-6. PMID: 19698412.
Copy Download .nbib Format: NLM
Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomnia.

European psychiatry : the journal of the Association of European Psychiatrists

Hajak G, Clarenbach P, Fischer W, Haase W, Bandelow B, Adler L, Rüther E.
PMID: 19698415
Eur Psychiatry. 1995;10:173s-9s. doi: 10.1016/0924-9338(96)80100-3.

The effect of treatment (28 days) with zopiclone, triazolam, flunitrazepam and placebo on sleep quality and daytime well-being was proven in a randomised, double-blind, parallel group, multicentre study in private practice. Results of an exploratory statistic of treatment efficacy...

Cite
Hajak G, Clarenbach P, Fischer W, et al. Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomnia. Eur Psychiatry. 1995;10:173s-9sdoi: 10.1016/0924-9338(96)80100-3.
Hajak, G., Clarenbach, P., Fischer, W., Haase, W., Bandelow, B., Adler, L., & Rüther, E. (1995). Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomnia. European psychiatry : the journal of the Association of European Psychiatrists, 10173s-9s. https://doi.org/10.1016/0924-9338(96)80100-3
Hajak, G, et al. "Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomnia." European psychiatry : the journal of the Association of European Psychiatrists vol. 10 (1995): 173s-9s. doi: https://doi.org/10.1016/0924-9338(96)80100-3
Hajak G, Clarenbach P, Fischer W, Haase W, Bandelow B, Adler L, Rüther E. Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomnia. Eur Psychiatry. 1995;10:173s-9s. doi: 10.1016/0924-9338(96)80100-3. PMID: 19698415.
Copy Download .nbib Format: NLM
Medications prescribed and occurrence of falls in general medicine inpatients.

The Canadian journal of hospital pharmacy

Cashin RP, Yang M.
PMID: 22479083
Can J Hosp Pharm. 2011 Sep;64(5):321-6. doi: 10.4212/cjhp.v64i5.1066.

BACKGROUND: Although falls are multifactorial, medications are a key risk factor that may be modifiable. Falls were among the most common occurrences entered into a risk identification system at the authors' hospital.OBJECTIVES: To identify whether general medicine inpatients who...

Cite
Cashin RP, Yang M. Medications prescribed and occurrence of falls in general medicine inpatients. Can J Hosp Pharm. 2011;64(5):321-6doi: 10.4212/cjhp.v64i5.1066.
Cashin, R. P., & Yang, M. (2011). Medications prescribed and occurrence of falls in general medicine inpatients. The Canadian journal of hospital pharmacy, 64(5), 321-6. https://doi.org/10.4212/cjhp.v64i5.1066
Cashin, Richard P, and Yang, Meiti. "Medications prescribed and occurrence of falls in general medicine inpatients." The Canadian journal of hospital pharmacy vol. 64,5 (2011): 321-6. doi: https://doi.org/10.4212/cjhp.v64i5.1066
Cashin RP, Yang M. Medications prescribed and occurrence of falls in general medicine inpatients. Can J Hosp Pharm. 2011 Sep;64(5):321-6. doi: 10.4212/cjhp.v64i5.1066. PMID: 22479083; PMCID: PMC3203823.
Copy Download .nbib Format: NLM
A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients.

Neuropsychiatric disease and treatment

Chen LF, Lin CE, Chou YC, Mao WC, Chen YC, Tzeng NS.
PMID: 23976857
Neuropsychiatr Dis Treat. 2013;9:1159-62. doi: 10.2147/NDT.S48152. Epub 2013 Aug 09.

OBJECTIVE: Complex sleep behaviors (CSBs) are classified as "parasomnias" in the International Classifcation of Sleep Disorders, Second Edition (ICSD-2). To realize the potential danger after taking two short-acting Z-hypnosedative drugs, we estimated the incidence of CSBs in nonpsychotic patients...

Cite
Chen LF, Lin CE, Chou YC, et al. A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients. Neuropsychiatr Dis Treat. 2013;9:1159-62doi: 10.2147/NDT.S48152.
Chen, L. F., Lin, C. E., Chou, Y. C., Mao, W. C., Chen, Y. C., & Tzeng, N. S. (2013). A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients. Neuropsychiatric disease and treatment, 91159-62. https://doi.org/10.2147/NDT.S48152
Chen, Li-Fen, et al. "A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients." Neuropsychiatric disease and treatment vol. 9 (2013): 1159-62. doi: https://doi.org/10.2147/NDT.S48152
Chen LF, Lin CE, Chou YC, Mao WC, Chen YC, Tzeng NS. A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients. Neuropsychiatr Dis Treat. 2013;9:1159-62. doi: 10.2147/NDT.S48152. Epub 2013 Aug 09. PMID: 23976857; PMCID: PMC3747020.
Copy Download .nbib Format: NLM
Indirect synchronous fluorescence spectroscopy and direct high-performance thin-layer chromatographic methods for enantioseperation of zopiclone and determination of chiral-switching eszopiclone: Evaluation of thermodynamic quantities of chromatographic separation.

Chirality

Moussa BA, Youssef NF, Elkady EF, Mohamed MF.
PMID: 30859633
Chirality. 2019 May;31(5):362-374. doi: 10.1002/chir.23063. Epub 2019 Mar 12.

Economic and enantioselective synchronous fluorescence spectroscopy and high-performance thin-layer chromatography methods have been developed and validated as per ICH guidelines for the separation of zopiclone enantiomers using L-(+)-tartaric acid as a chiral selector, followed by determination of the chiral-switching...

Cite
Moussa BA, Youssef NF, Elkady EF, et al. Indirect synchronous fluorescence spectroscopy and direct high-performance thin-layer chromatographic methods for enantioseperation of zopiclone and determination of chiral-switching eszopiclone: Evaluation of thermodynamic quantities of chromatographic separation. Chirality. 2019;31(5):362-374doi: 10.1002/chir.23063.
Moussa, B. A., Youssef, N. F., Elkady, E. F., & Mohamed, M. F. (2019). Indirect synchronous fluorescence spectroscopy and direct high-performance thin-layer chromatographic methods for enantioseperation of zopiclone and determination of chiral-switching eszopiclone: Evaluation of thermodynamic quantities of chromatographic separation. Chirality, 31(5), 362-374. https://doi.org/10.1002/chir.23063
Moussa, Bahia A, et al. "Indirect synchronous fluorescence spectroscopy and direct high-performance thin-layer chromatographic methods for enantioseperation of zopiclone and determination of chiral-switching eszopiclone: Evaluation of thermodynamic quantities of chromatographic separation." Chirality vol. 31,5 (2019): 362-374. doi: https://doi.org/10.1002/chir.23063
Moussa BA, Youssef NF, Elkady EF, Mohamed MF. Indirect synchronous fluorescence spectroscopy and direct high-performance thin-layer chromatographic methods for enantioseperation of zopiclone and determination of chiral-switching eszopiclone: Evaluation of thermodynamic quantities of chromatographic separation. Chirality. 2019 May;31(5):362-374. doi: 10.1002/chir.23063. Epub 2019 Mar 12. PMID: 30859633.
Copy Download .nbib Format: NLM
Sol-gel technique for the preparation of β-cyclodextrin gold nanoparticles as chiral stationary phase in open-tubular capillary electrochromatography.

Journal of separation science

Jiang Z, Qu J, Tian X, Huo X, Zhang J, Guo X, Fang L.
PMID: 30919564
J Sep Sci. 2019 May;42(10):1948-1954. doi: 10.1002/jssc.201900071. Epub 2019 Apr 16.

A novel open-tubular capillary electrochromatography column coated with β-cyclodextrin was prepared using the sol-gel technique. In the sol-gel approach, owing to the three-dimensional network of sol-gel and the strong chemical bond between the stationary phase and the surface of...

Cite
Jiang Z, Qu J, Tian X, et al. Sol-gel technique for the preparation of β-cyclodextrin gold nanoparticles as chiral stationary phase in open-tubular capillary electrochromatography. J Sep Sci. 2019;42(10):1948-1954doi: 10.1002/jssc.201900071.
Jiang, Z., Qu, J., Tian, X., Huo, X., Zhang, J., Guo, X., & Fang, L. (2019). Sol-gel technique for the preparation of β-cyclodextrin gold nanoparticles as chiral stationary phase in open-tubular capillary electrochromatography. Journal of separation science, 42(10), 1948-1954. https://doi.org/10.1002/jssc.201900071
Jiang, Zhen, et al. "Sol-gel technique for the preparation of β-cyclodextrin gold nanoparticles as chiral stationary phase in open-tubular capillary electrochromatography." Journal of separation science vol. 42,10 (2019): 1948-1954. doi: https://doi.org/10.1002/jssc.201900071
Jiang Z, Qu J, Tian X, Huo X, Zhang J, Guo X, Fang L. Sol-gel technique for the preparation of β-cyclodextrin gold nanoparticles as chiral stationary phase in open-tubular capillary electrochromatography. J Sep Sci. 2019 May;42(10):1948-1954. doi: 10.1002/jssc.201900071. Epub 2019 Apr 16. PMID: 30919564.
Copy Download .nbib Format: NLM
Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon.

Journal of sleep research

Torres R, Fisher M, Birznieks G, Polymeropoulos C, Kay GG, Xiao C, Polymeropoulos MH.
PMID: 34152055
J Sleep Res. 2021 Jun 21;e13430. doi: 10.1111/jsr.13430. Epub 2021 Jun 21.

An impairment in next day driving performance has been reported for almost every drug currently United States Food and Drug Administration (FDA) approved for improvement of sleep in chronic and transient insomnia. Tasimelteon, a melatonin receptor agonist, demonstrated significant...

Cite
Torres R, Fisher M, Birznieks G, et al. Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon. J Sleep Res. 2021;e13430doi: 10.1111/jsr.13430.
Torres, R., Fisher, M., Birznieks, G., Polymeropoulos, C., Kay, G. G., Xiao, C., & Polymeropoulos, M. H. (2021). Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon. Journal of sleep research, e13430. https://doi.org/10.1111/jsr.13430
Torres, Rosarelis, et al. "Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon." Journal of sleep research vol. (2021): e13430. doi: https://doi.org/10.1111/jsr.13430
Torres R, Fisher M, Birznieks G, Polymeropoulos C, Kay GG, Xiao C, Polymeropoulos MH. Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon. J Sleep Res. 2021 Jun 21;e13430. doi: 10.1111/jsr.13430. Epub 2021 Jun 21. PMID: 34152055.
Copy Download .nbib Format: NLM
Use of potentially driver-impairing drugs among older drivers.

BMC geriatrics

Zitoun S, Baudouin E, Corruble E, Vidal JS, Becquemont L, Duron E.
PMID: 34979970
BMC Geriatr. 2022 Jan 03;22(1):4. doi: 10.1186/s12877-021-02726-5.

BACKGROUND: Road safety is a major issue among seniors. Potentially Driver-Impairing (PDI) drugs are known to increase the risk of car accident. The aim of this cross-sectional study was to describe PDI-drug consumption among older drivers and determine associated...

Cite
Zitoun S, Baudouin E, Corruble E, et al. Use of potentially driver-impairing drugs among older drivers. BMC Geriatr. 2022;22(1):4doi: 10.1186/s12877-021-02726-5.
Zitoun, S., Baudouin, E., Corruble, E., Vidal, J. S., Becquemont, L., & Duron, E. (2022). Use of potentially driver-impairing drugs among older drivers. BMC geriatrics, 22(1), 4. https://doi.org/10.1186/s12877-021-02726-5
Zitoun, Sarah, et al. "Use of potentially driver-impairing drugs among older drivers." BMC geriatrics vol. 22,1 (2022): 4. doi: https://doi.org/10.1186/s12877-021-02726-5
Zitoun S, Baudouin E, Corruble E, Vidal JS, Becquemont L, Duron E. Use of potentially driver-impairing drugs among older drivers. BMC Geriatr. 2022 Jan 03;22(1):4. doi: 10.1186/s12877-021-02726-5. PMID: 34979970; PMCID: PMC8722131.
Copy Download .nbib Format: NLM
The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Louzada LL, Machado FV, Quintas JL, Ribeiro GA, Silva MV, Mendonça-Silva DL, Gonçalves BSB, Nóbrega OT, Camargos EF.
PMID: 34635802
Neuropsychopharmacology. 2022 Jan;47(2):570-579. doi: 10.1038/s41386-021-01191-3. Epub 2021 Oct 11.

No prior studies have evaluated the efficacy and safety of zolpidem and zopiclone to treat insomnia of demented patients. This randomized, triple-blind, placebo-controlled clinical trial used these drugs to treat patients with probable, late onset Alzheimer's dementia (AD) (DSM...

Cite
Louzada LL, Machado FV, Quintas JL, et al. The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial. Neuropsychopharmacology. 2021;47(2):570-579doi: 10.1038/s41386-021-01191-3.
Louzada, L. L., Machado, F. V., Quintas, J. L., Ribeiro, G. A., Silva, M. V., Mendonça-Silva, D. L., Gonçalves, B. S. B., Nóbrega, O. T., & Camargos, E. F. (2022). The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 47(2), 570-579. https://doi.org/10.1038/s41386-021-01191-3
Louzada, Luciana L, et al. "The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 47,2 (2022): 570-579. doi: https://doi.org/10.1038/s41386-021-01191-3
Louzada LL, Machado FV, Quintas JL, Ribeiro GA, Silva MV, Mendonça-Silva DL, Gonçalves BSB, Nóbrega OT, Camargos EF. The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial. Neuropsychopharmacology. 2022 Jan;47(2):570-579. doi: 10.1038/s41386-021-01191-3. Epub 2021 Oct 11. PMID: 34635802; PMCID: PMC8674235.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 73 entries